1. Home
  2. CYTK vs NXT Comparison

CYTK vs NXT Comparison

Compare CYTK & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • NXT
  • Stock Information
  • Founded
  • CYTK 1997
  • NXT 2013
  • Country
  • CYTK United States
  • NXT United States
  • Employees
  • CYTK 564
  • NXT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • NXT Semiconductors
  • Sector
  • CYTK Health Care
  • NXT Technology
  • Exchange
  • CYTK Nasdaq
  • NXT Nasdaq
  • Market Cap
  • CYTK 5.8B
  • NXT 5.7B
  • IPO Year
  • CYTK 2004
  • NXT 2023
  • Fundamental
  • Price
  • CYTK $48.87
  • NXT $35.15
  • Analyst Decision
  • CYTK Buy
  • NXT Buy
  • Analyst Count
  • CYTK 16
  • NXT 19
  • Target Price
  • CYTK $84.07
  • NXT $52.00
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • NXT 2.1M
  • Earning Date
  • CYTK 11-06-2024
  • NXT 01-29-2025
  • Dividend Yield
  • CYTK N/A
  • NXT N/A
  • EPS Growth
  • CYTK N/A
  • NXT 306.64
  • EPS
  • CYTK N/A
  • NXT 3.98
  • Revenue
  • CYTK $3,219,000.00
  • NXT $2,802,433,000.00
  • Revenue This Year
  • CYTK N/A
  • NXT $15.25
  • Revenue Next Year
  • CYTK $795.25
  • NXT $10.76
  • P/E Ratio
  • CYTK N/A
  • NXT $8.82
  • Revenue Growth
  • CYTK N/A
  • NXT 34.43
  • 52 Week Low
  • CYTK $43.21
  • NXT $30.93
  • 52 Week High
  • CYTK $110.25
  • NXT $62.31
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • NXT 44.22
  • Support Level
  • CYTK $45.66
  • NXT $34.54
  • Resistance Level
  • CYTK $49.40
  • NXT $37.29
  • Average True Range (ATR)
  • CYTK 1.71
  • NXT 1.88
  • MACD
  • CYTK -0.20
  • NXT -0.35
  • Stochastic Oscillator
  • CYTK 50.79
  • NXT 27.60

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About NXT Nextracker Inc.

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Share on Social Networks: